WAVE Life Sciences Ltd.
WVE
$6.59
$0.0450.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 243.08M | 302.08M | 310.95M | 153.96M | 180.92M |
| Total Receivables | -- | 1.42M | -- | 1.29M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.06M | 9.54M | 10.57M | 12.15M | 11.14M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.84M | 7.35M | 3.00M | 4.68M | 4.71M |
| Total Current Assets | 257.98M | 320.39M | 324.52M | 172.08M | 196.77M |
|
|
|||||
| Total Current Assets | 257.98M | 320.39M | 324.52M | 172.08M | 196.77M |
| Net Property, Plant & Equipment | 26.15M | 28.00M | 30.05M | 32.11M | 33.92M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.22M | 3.82M | 3.94M | 4.63M | 4.58M |
| Total Assets | 288.34M | 352.21M | 358.50M | 208.82M | 235.27M |
|
|
|||||
| Total Accounts Payable | 14.36M | 16.26M | 12.78M | 18.15M | 11.73M |
| Total Accrued Expenses | 7.81M | 21.08M | 14.64M | 10.68M | 6.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.88M | 7.64M | 7.40M | 7.16M | 6.94M |
| Total Finance Division Other Current Liabilities | 57.31M | 65.97M | 135.91M | 137.14M | 140.59M |
| Total Other Current Liabilities | 57.31M | 65.97M | 135.91M | 137.14M | 140.59M |
| Total Current Liabilities | 87.37M | 110.95M | 170.73M | 173.13M | 165.87M |
|
|
|||||
| Total Current Liabilities | 87.37M | 110.95M | 170.73M | 173.13M | 165.87M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.72M | 17.77M | 19.77M | 21.71M | 23.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.58M | 6.10M | 18.49M | 9.58M | 12.54M |
| Total Liabilities | 108.67M | 134.82M | 208.99M | 204.42M | 202.01M |
|
|
|||||
| Common Stock & APIC | 1.34B | 1.33B | 1.29B | 1.09B | 1.08B |
| Retained Earnings | -1.17B | -1.12B | -1.15B | -1.09B | -1.06B |
| Treasury Stock & Other | -204.00K | -262.00K | -159.00K | -279.00K | -198.00K |
| Total Common Equity | 171.80M | 209.52M | 141.64M | -3.48M | 25.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
|
|
|||||
| Total Common Equity | 171.80M | 209.52M | 141.64M | -3.48M | 25.39M |
| Total Preferred Equity | 7.87M | 7.87M | 7.87M | 7.87M | 7.87M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 179.68M | 217.39M | 149.51M | 4.40M | 33.26M |
|
|
|||||